OK Biotech Co., Ltd. (TPE:4155)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
13.75
-0.25 (-1.79%)
Mar 9, 2026, 1:30 PM CST
-35.90%
Market Cap 1.94B
Revenue (ttm) 1.64B
Net Income (ttm) 68.75M
Shares Out 141.38M
EPS (ttm) 0.47
PE Ratio 29.11
Forward PE n/a
Dividend 0.30 (2.14%)
Ex-Dividend Date Jul 4, 2025
Volume 373,663
Average Volume 157,214
Open 13.85
Previous Close 14.00
Day's Range 13.45 - 13.85
52-Week Range 13.75 - 21.70
Beta 0.15
RSI 29.63
Earnings Date Mar 26, 2026

About OK Biotech

OK Biotech Co., Ltd. develops, manufactures, markets, and sells blood glucose monitoring systems and homecare healthcare devices in Taiwan and internationally. It also offers OTC hearing aids, multi-frequency therapy devices, and factory setup solutions. The company was founded in 2004 and is based in Hsinchu City, Taiwan. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2004
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 4155
Full Company Profile

Financial Performance

In 2024, OK Biotech's revenue was 1.67 billion, an increase of 40.11% compared to the previous year's 1.19 billion. Earnings were 93.98 million, an increase of 3087.75%.

Financial Statements

News

There is no news available yet.